quinacrine has been researched along with Dysentery, Shiga bacillus in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kradolfer, F | 1 |
Jarumilinta, R | 1 |
Sackmann, W | 1 |
Klokova, GF | 1 |
Astapov, AA | 1 |
2 other studies available for quinacrine and Dysentery, Shiga bacillus
Article | Year |
---|---|
The amoebicidal, trichomonicidal, and antibacterial effects of niridazole in laboratory animals.
Topics: Amebiasis; Amebicides; Amoeba; Animals; Anthelmintics; Antimony; Antiprotozoal Agents; Chloroquine; | 1969 |
[Aminoacrichine in the complex treatment of patients with acute dysentery].
Topics: Drug Resistance, Microbial; Dysentery, Bacillary; Escherichia coli; Humans; Quinacrine | 1972 |